�㽶��Ƶ

In a rare but serious complication of cancer, the body’s own immune system can start attacking the brain, causing rapid-onset memory loss and cognitive deficits. What triggers this sudden biological...

Moriel Zelikowsky, Ph.D., an assistant professor of neurobiology at the Spencer Fox Eccles School of Medicine at the �㽶��Ƶ of Utah, has received a 2023 McKnight Scholar Award in recognition...

�㽶��Ƶ of Utah Health scientists discovered insights into the importance of a minor cell type in the brain—microglia—in controlling anxiety-related behaviors. The findings could lead to new approaches for targeted...

A new study with mice, that could have implications for people, suggests that some decisions are hard-wired and largely beyond their control.

Children are at increased risk of stroke after COVID-19 infection, according to a new study by scientists at �㽶��Ƶ of Utah Health.

Whatever you do, don’t call them "mini-brains," say �㽶��Ƶ of Utah Health scientists. Regardless, the seed-sized organoids—which are grown in the lab from human cells—are providing insights into the brain...

Whatever you do, don’t call them “mini-brains,” say �㽶��Ƶ of Utah Health scientists. Regardless, the seed-sized organoids—which are grown in the lab from human cells—are providing insights into the brain...

The �㽶��Ƶ of Utah College of Pharmacy’s Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $34 million contract renewal with the NIH’s National Institute of Neurological Disorders and...

Stefan M. Pulst, M.D., Dr. med., professor and chair of the Department of Neurology at �㽶��Ƶ of Utah Health, is one of nine recipients nationwide of the 2022 R35 Outstanding...

Preventing the formation of a sticky, web-like substance that can form in blood vessels after a stroke could protect the brain and lead to better outcomes for patients, studies in...

�㽶��Ƶ of Utah Health and Intermountain Healthcare are taking part in an international study to help determine if high intensity exercise can slow the progression of Parkinson’s disease.

U of U Health scientists have identified a molecule that slows cells’ production of alpha-synuclein, a protein that forms toxic aggregates in the brains of people with Parkinson’s disease.